COR logo Cencora +
Cencora
+

Cencora (COR) Business News

Track Cencora in real time with a live news feed covering Cencora stock news, official press releases, company announcements, and an archive of historical Cencora news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

23,420 Cencora, Inc. $COR Shares Bought by NorthCrest Asset Manangement LLC

Defense World

7:55 AM | Tuesday | Oct 13, 2026

news photo
Loading...

NorthCrest Asset Manangement LLC increased its holdings in Cencora, Inc. (NYSE: COR) by 1,255.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 25,286 shares of the company's stock after buying an additional 23,420 shares during the quarter. NorthCrest Asset

Read full article redirect
7:55 AM | Tuesday | Oct 13, 2026

23,420 Cencora, Inc. $COR Shares Bought by NorthCrest Asset Manangement LLC

Defense World

NorthCrest Asset Manangement LLC increased its holdings in Cencora, Inc. (NYSE: COR) by 1,255.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 25,286 shares of the company's stock after buying an additional 23,420 shares during the quarter. NorthCrest Asset

Read full article arrow
News Thumbnail
1:28 AM | Monday | Oct 12, 2026

Hims & Hers Health (NYSE:HIMS) vs. Cencora (NYSE:COR) Head to Head Review

Defense World

Cencora (NYSE: COR - Get Free Report) and Hims and Hers Health (NYSE: HIMS - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk. Valuation and Earnings This table compares Cencora

Read full article arrow
News Thumbnail
3:48 AM | Tuesday | Oct 6, 2026

Cencora Remains A Buy At These Prices, As Healthcare Supply-Chain Needs Grow

Seeking Alpha

Cencora gets its prior buy rating reaffirmed again. Despite some market underperformance, specific business and macro fundamentals remain supportive. An investment-grade rating, positive operating cash flow, dividend safety, and an improved operating margin underscore the thesis.

Read full article arrow
News Thumbnail
8:00 AM | Friday | Oct 2, 2026

Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release

Business Wire

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2026 on Wednesday, November 4, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m.
ET on November 4, 2026.Participating in the conference call will be:Robert P. Mauch, President & Chief Executive OfficerEva C. Boratto, Executive Vice President & Chie.

Read full article arrow
News Thumbnail
8:00 AM | Friday | Sep 25, 2026

Cencora Elects Robert E. Sanchez to Its Board of Directors

Business Wire

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Robert E. Sanchez as a new independent director, effective October 1, 2026. Mr.
Sanchez is the Executive Chair of Ryder System, Inc., where he previously served as Chair and Chief Executive Officer until his retirement in March 2026. Prior to being appointed CEO in 2013, Mr. Sanchez spent two decades with Ryder serving in roles of increasing responsibility including President an.

Read full article arrow
News Thumbnail
10:45 AM | Wednesday | Sep 23, 2026

Here's Why Cencora (COR) is a Strong Growth Stock

Zacks Investment Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read full article arrow
News Thumbnail
6:03 AM | Monday | Sep 21, 2026

Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference

Defense World

Cencora (NYSE: COR) executives highlighted the company's specialty pharmaceutical positioning, medical specialty organization strategy and capital-allocation priorities during an investor conference discussion, while reaffirming the durability of its relationship with Walgreens. Chief Executive Officer Bob Mauch said Cencora's growth is being supported by pharmaceutical innovation, demographic trends and the company's long-standing investments in specialty distribution and

Read full article arrow
News Thumbnail
6:02 AM | Monday | Sep 21, 2026

Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference

MarketBeat

Cencora NYSE: COR executives highlighted the company's specialty pharmaceutical positioning, medical specialty organization strategy and capital-allocation priorities during an investor conference discussion, while reaffirming the durability of its relationship with Walgreens.

Read full article arrow
News Thumbnail
10:41 AM | Friday | Sep 18, 2026

Here's Why Cencora (COR) is a Strong Value Stock

Zacks Investment Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read full article arrow
News Thumbnail
3:26 AM | Thursday | Sep 17, 2026

Corient Private Wealth LP Purchases 19,068 Shares of Cencora, Inc. $COR

Defense World

Corient Private Wealth LP lifted its holdings in Cencora, Inc. (NYSE: COR) by 102.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 37,601 shares of the company's stock after buying an additional 19,068 shares during the period. Corient Private Wealth LP's

Read full article arrow
News Thumbnail